SWTX

44.13

6.92% -3.28

Handel nachbörslich: 43.99 -0.14 -0.32%

Springworks Therapeutics Inc (SWTX)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$47.41

Offen:

$45.7

24-Stunden-Volumen:

2.41M

Relative Volume:

1.07

Marktkapitalisierung:

$3.64B

Einnahmen:

Nettoeinkommen (Verlust:

$-275.16M

KGV:

-11.34

EPS:

-3.89

Netto-Cashflow:

$-221.15M

1W Leistung:

-9.03%

1M Leistung:

-23.60%

6M Leistung:

+37.73%

1J Leistung:

-10.34%

1-Tages-Spanne:

$43.76

$46.00

1-Wochen-Bereich:

$43.76

$48.62

52-Wochen-Spanne:

$28.21

$62.00

Springworks Therapeutics Inc Stock (SWTX) Company Profile

Firmenname

Springworks Therapeutics Inc

Sektor

Healthcare (1164)

Branche

Biotechnology (681)

Telefon

203-883-9490

Adresse

100 WASHINGTON BOULEVARD, STAMFORD, CT

Mitarbeiter

Twitter

@springworkstx

Nächster Verdiensttermin

2024-11-12

Neueste SEC-Einreichungen

SWTX's Discussions on Twitter

Vergleichen Sie SWTX mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
SWTX Springworks Therapeutics Inc	44.13	3.64B	0	-275.16M	-221.15M	-3.89
VRTX Vertex Pharmaceuticals Inc	484.82	131.41B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	634.23	72.26B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	591.87	36.10B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	270.02	35.03B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	272.17	28.24B	3.81B	-644.79M	-669.77M	-6.24

Springworks Therapeutics Inc Stock (SWTX) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-11-20	Eingeleitet	Evercore ISI	Outperform
2024-02-05	Eingeleitet	Guggenheim	Buy
2022-12-01	Eingeleitet	BofA Securities	Buy
2021-01-19	Bestätigt	H.C. Wainwright	Buy
2020-10-29	Bestätigt	H.C. Wainwright	Buy
2020-05-05	Eingeleitet	Barclays	Overweight
2020-03-19	Hochstufung	H.C. Wainwright	Neutral → Buy
2020-03-04	Herabstufung	H.C. Wainwright	Buy → Neutral
2020-01-21	Bestätigt	H.C. Wainwright	Buy
2019-12-04	Eingeleitet	H.C. Wainwright	Buy
2019-10-08	Eingeleitet	Cowen	Outperform
2019-10-08	Eingeleitet	Goldman	Buy
2019-10-08	Eingeleitet	JP Morgan	Overweight
2019-10-08	Eingeleitet	Wedbush	Outperform

Alle ansehen

Springworks Therapeutics Inc Aktie (SWTX) Neueste Nachrichten

02:24 AM

BIT Capital GmbH Increases Stock Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat

02:24 AM

11:59 AM

Segall Bryant & Hamill LLC Acquires 58,522 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat

11:59 AM

Mar 29, 2025

Cibc World Markets Corp Takes $232,000 Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat

Mar 29, 2025

Mar 28, 2025

SpringWorks Therapeutics (NASDAQ:SWTX) Stock Price Down 2.5%Time to Sell? - MarketBeat

Mar 28, 2025

Mar 25, 2025

SpringWorks Therapeutics Target of Unusually Large Options Trading (NASDAQ:SWTX) - MarketBeat

Mar 25, 2025

Mar 24, 2025

Neurofibromatosis Type 2 Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Recursion Pharma, Vivace Therapeutics, Healx Limited, SpringWorks Therapeutics - Barchart

Mar 24, 2025

Neurofibromatosis Type 2 Pipeline 2025: Key Companies, MOA, - openPR

Mar 24, 2025

Raymond James Financial Inc. Invests $10.53 Million in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat

Mar 24, 2025

Mar 23, 2025

46,895 Shares in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Purchased by Platinum Investment Management Ltd. - MarketBeat

Mar 23, 2025

Mar 21, 2025

SpringWorks Therapeutics (NASDAQ:SWTX) Shares Down 4.8%Should You Sell? - MarketBeat

Mar 21, 2025

SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Short Interest Update - MarketBeat

Mar 21, 2025

Mar 20, 2025

Mineralys, Tenaya, SpringWorks, COSCIENS, Metagenomi: 5 Biotech Stocks That Led Retail Follower Growth Last Week - MSN

Mar 20, 2025

Mar 19, 2025

FDA’s new and supplemental approvals in February - BioCentury

Mar 19, 2025

Bank of New York Mellon Corp Sells 30,986 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat

Mar 19, 2025

Mar 18, 2025

This Is What Whales Are Betting On SpringWorks Therapeutics - Benzinga

Mar 18, 2025

Mar 17, 2025

SpringWorks Therapeutics and Jewelry Designer Jennifer Fisher Te - GuruFocus.com

Mar 17, 2025

Mar 15, 2025

SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Shares Sold by Victory Capital Management Inc. - MarketBeat

Mar 15, 2025

Mar 13, 2025

High Growth Tech Stocks In The US Market March 2025 - Simply Wall St

Mar 13, 2025

How To Trade (SWTX) - Stock Traders Daily

Mar 13, 2025

Mar 12, 2025